|
"lane hy"的相關文件
顯示項目 16-25 / 48 (共5頁)
<< < 1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
| 中國醫藥大學 |
2005 |
A functional polymorphism in the promoter region of the tryptophan hydroxylase gene is associated with alcohol dependence in one aboriginal group in Taiwan
|
Sun, HS; Fann, CSJ; Lane, HY; Chang, YT; Chang, CJ; Liu, YL; Cheng, ATA |
| 中國醫藥大學 |
2005 |
Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics
|
Lane, HY; Lee, CC; Liu, YC; Chang, WH |
| 中國醫藥大學 |
2005 |
Regular-dose risperidone on QTc intervals
|
Chiu, CC; Chang, WH; Huang, MC; Chin, YW; Lane, HY |
| 中國醫藥大學 |
2005 |
Doparnine D-3 receptor Ser9GIy polymorphism and risperidone response
|
Lane, HY; Hsu, SK; Liu, YC; Chang, YC; Huang, CH; Chang, WH |
| 中國醫藥大學 |
2005 |
Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics
|
Lane, HY; Lee, CC; Liu, YC; Chang, WH |
| 中國醫藥大學 |
2004 |
Olanzapine-induced QTc prolongation in a patient with Wolff-Parkinson-White syndrome
|
Su, KP; Lane, HY; Chuang, CL; Chen, KP; Shen, WW |
| 中國醫藥大學 |
2004 |
Effects of dopamine D-2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function
|
Lane, HY; Lee, CC; Chang, YC; Lu, CT; Huang, CH; Chang, WH |
| 中國醫藥大學 |
2004 |
Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophrenia
|
Chiu, CC; Lane, HY; Huang, MC; Liu, HC; Jann, MW; Hon, YY; Chang, WH; Lu, ML |
| 中國醫藥大學 |
2004 |
Adjunctive fluvoxamine inhibits clozapine-related weight gain and metabolic disturbances
|
Lu, ML; Lane, HY; Lin, SK; Chen, KP; Chang, WH |
| 中國醫藥大學 |
2004 |
Fine-tuning risperidone dosage for acutely exacerbated schizophrenia: clinical determinants
|
Lane, HY; Chang, YC; Chiu, CC; Lee, SH; Lin, CY; Chang, WH |
顯示項目 16-25 / 48 (共5頁)
<< < 1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
|
